@article{e009973ac5214250b3d1a20447035d5e,
title = "Palliative care, version 2.2021 featured updates to the nccn guidelines",
abstract = "Palliative care has evolvedtobeanintegral part of comprehensive cancer carewith thegoal of early intervention toimprove quality of life and patient outcomes. The NCCN Guidelines for Palliative Care provide recommendations to help the primary oncology team promote the best quality of life possible throughout the illness trajectory for each patient with cancer. The NCCN Palliative Care Panel meets annually to evaluate and update recommendations based on panel members' clinical expertise and emerging scientific data. These NCCN Guidelines Insights summarize the panel's recent discussions and highlights updates on the importance of fostering adaptive coping strategies for patients and families, and on the role of pharmacologic and nonpharmacologic interventions to optimize symptom management.",
author = "Maria Dans and Kutner, {Jean S.} and Rajiv Agarwal and Baker, {Justin N.} and Bauman, {Jessica R.} and Beck, {Anna C.} and Campbell, {Toby C.} and Carey, {Elise C.} and Case, {Amy A.} and Shalini Dalal and Doberman, {Danielle J.} and Epstein, {Andrew S.} and Leslie Fecher and Joshua Jones and Jennifer Kapo and Lee, {Richard T.} and Loggers, {Elizabeth T.} and Susan McCammon and William Mitchell and Ogunseitan, {Adeboye B.} and Portman, {Diane G.} and Kavitha Ramchandran and Linda Sutton and Jennifer Temel and Teply, {Melissa L.} and Terauchi, {Stephanie Y.} and Jane Thomas and Walling, {Anne M.} and Finly Zachariah and Bergman, {Mary Anne} and Ndiya Ogba and Mallory Campbell",
note = "Funding Information: This activity is supported by educational grants from Agios Pharmaceuticals; AstraZeneca; Clovis Oncology, Inc.; Daiichi Sankyo; Eisai; Epizyme Inc.; Novartis; and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. This activity is supported by an independent medical education grant from Bristol-Myers Squibb, and Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is supported by an independent medical educational grant from Mylan Inc. This activity is supported by a medical education grant from Karyopharm Therapeutics. This activity is supported by an independent educational grant from AbbVie. Publisher Copyright: {\textcopyright} National Comprehensive Cancer Network, Inc. 2021.",
year = "2021",
month = jul,
doi = "10.6004/jnccn.2021.0033",
language = "English (US)",
volume = "19",
pages = "780--788",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "7",
}